Roth Capital restated their buy rating on shares of Hut 8 (NASDAQ:HUT – Free Report) in a research report sent to investors on Monday, MarketBeat reports. They currently have a $60.00 price target on the stock, up from their previous price target of $31.00. A number of other equities research analysts also recently weighed in […]

Roth Capital restated their buy rating on shares of Rezolve AI (NASDAQ:RZLV – Free Report) in a research note published on Monday morning, Marketbeat Ratings reports. Roth Capital currently has a $9.00 target price on the stock, up from their prior target price of $4.25. Several other research analysts have also commented on the company. […]

Aptevo Therapeutics (NASDAQ:APVO – Get Free Report) was upgraded by investment analysts at Roth Capital to a “strong-buy” rating in a research note issued on Tuesday,Zacks.com reports. Separately, Wall Street Zen raised Aptevo Therapeutics from a “sell” rating to a “hold” rating in a research note on Saturday, August 16th. One research analyst has rated […]